The FDA has issued a warning to veterinarians about potential adverse effects in dogs receiving Librela injections. The drug, used to treat osteoarthritis pain, has been linked to neurological problems, physical issues, and even death.
The Food and Drug Administration's ( FDA ) Center for Veterinary Medicine posted a letter to veterinarians on Monday warning about adverse effects reported in dogs following injections of Librela , a treatment aimed at providing pain relief for dogs with osteoarthritis.Dogster reports that there are an estimated 86.9 million dogs in the U.S.
The Morris Animal Foundation said about 14 million of those dogs live with osteoarthritis, also known as degenerative joint disease, which is a 'progressive disease of the joints fueled by chronic inflammation. The end result is chronic pain that can have far-ranging, negative health effects beyond an affected joint.' The FDA warned of several neurological and physical problems in dogs after receiving Librela injections.The letter comes after several reports revealed the adverse effects of the drug.The letter details several side effects, including ataxia—which causes lack of muscle control and coordination, seizures, paresis, recumbency, urinary incontinence, polyuria, and polydipsia.The most intense side effect is death, both naturally and by euthanasia.Users on a Facebook group, Librela: The REAL Truth in Testimony, often post about side effects they've noticed in their dogs who have been treated with the injection, some noticing spasms, neurological problems, and lack of appetite, among other effects. Librela, sponsored by Zoetis, is a monoclonal antibody drug that was approved by the FDA on May 5, 2023. Veterinarians administer the drug as a once-a-month injection, with the dosage determined by the dog's weight. It is available as a 5, 10, 15, 20, or 30 mg/ml solution injection
FDA Librela Osteoarthritis Dogs Side Effects
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Warns of Serious Side Effects from Librela, a Common Dog Pain DrugThe FDA is warning dog owners about serious side effects associated with Librela, a pain medication commonly used for dogs with osteoarthritis. The agency received reports of dogs experiencing severe symptoms, including muscle weakness, seizures, and even death, after being treated with Librela.
Read more »
FDA Warns About Unapproved Semaglutide Alternatives Amid Weight Loss Drug ShortagesThe Federal Drug Administration (FDA) has issued warnings to consumers regarding unapproved alternatives to semaglutide, a popular weight loss drug sold under brand names Ozempic and Wegovy. With shortages and high costs driving consumers to seek other options, experts caution against compounded versions which lack the same level of control.
Read more »
Tom's of Maine Toothpaste Contaminated with Bacteria, FDA WarnsA warning letter from the FDA revealed that Tom's of Maine toothpaste was manufactured with water containing harmful bacteria like Pseudomonas aeruginosa and Ralstonia insidiosa. A 'black mold-like substance' was also discovered in the factory. The company is working with the FDA to address the issues.
Read more »
Doctor warns of ‘youth vape epidemic' as FDA battles vaping industryThe Supreme Court on Monday heard arguments in a battle between the Federal Drug Administration and two vape manufacturers regarding whether the FDA unlawfully…
Read more »
FDA warns about men's supplements tainted with prescription drugsThey're widely marketed to men for performance, energy and sex drive. What you need to know to stay safe.
Read more »
Men's Supplements Contain 'Hidden' Prescription Drugs, FDA WarnsSince becoming a freelance writer in 2019, Emily has developed significant experience covering viral pop culture moments and trending news topics in the health and wellness space, while also writing about mental health, relationships, and smarter living.
Read more »